Precision for Medicine receives $75 million investment – Medical Marketing & Media
TPG’s $75 million investment in Precision Medical Group is featured in Medical Marketing & Media.
TPG Invests $75 Million into Precision For Medicine – PharmaLive
PharmaLive covers TPG’s significant investment in Precision Medicine Group
TPG bets $75M on Pharma Service Provider Precision for Medicine – FierceCRO
TPG partner Kevin Hobart discusses the equity firm’s investment in Precision Medicine Group with Damian Garde for Fierce Biotech,
TPG Growth Invests $75 Million in Precision for Medicine
Leader in Healthcare Investing Acquires Stake in Growing Pharmaceutical Services Company
Fort Worth, Texas, San Francisco and Bethesda, MD — December 22, 2015 — TPG Growth, the middle market and growth equity investment platform of TPG, a leading global private investment firm with approximately $70 billion of assets under management, today announced a $75 million investment in Precision for Medicine, Inc. Additional details of the transaction were not disclosed.
Congress Considers Regulation of Lab-Developed Tests – Roll Call
Precision for Medicine’s Karen M. Becker, PhD, Managing Director, Translational and Regulatory Science, is quoted in an article regarding the upcoming Food and Drug Administration’s guidance on how it plans to oversee lab-developed tests used to diagnose conditions. Read the full article below:
By Andrew Siddons